Emerging Infectious Diseases Laboratory

Emerging Infectious Diseases Laboratory

Emerging Infectious Diseases Laboratory

Setting New Standards for Biosafety Excellence

The U.S. Centers for Disease Control and Prevention’s new, highest-level biosafety containment facility — the Emerging Infectious Diseases Laboratory — is the largest facility of its kind in the world. The new facility includes BSL-4 laboratories capable of handling life-threatening and exotic pathogens for which there are no treatments or vaccines establishing new criteria and standards of excellence for biosafety.

Innovative features include:

  • Multiple combinations of BSL-3 and BSL-4 modules and shared specimen support space to provide expanded mission critical space and improved flexibility.
  • Extensive use of daylighting and exterior views to create open and bright spaces.
  • Colocation of formerly disparate groups into one cohesive unit to create a foundation for scientific collaboration.
  • Highly flexible casework designed to change as the program changes.
  • A new campus utility plant and distribution system designed to support the increased infrastructure demands of the new facility.
Emerging Infectious Diseases Laboratory
Client
U.S. Centers for Disease Control and Prevention
Location

Atlanta, GA
United States

Size
420,000 SF (39,000 m²)